EAM Investors, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$1,773,164
-9.7%
22,545
-15.0%
0.37%
-14.1%
Q3 2022$1,964,000
+34.2%
26,532
+18.2%
0.43%
+19.6%
Q2 2022$1,463,000
-33.2%
22,450
+29.3%
0.36%
-38.3%
Q3 2019$2,191,000
+3.4%
17,369
-1.3%
0.58%
+11.8%
Q2 2019$2,118,000
+0.8%
17,596
-16.2%
0.52%
-9.3%
Q4 2018$2,102,000
-48.4%
21,006
-40.9%
0.57%
-5.6%
Q3 2018$4,071,000
+18.8%
35,527
-7.1%
0.60%
+11.8%
Q2 2018$3,428,000
+11.4%
38,228
-9.2%
0.54%
+5.7%
Q1 2018$3,078,00042,0790.51%
Other shareholders
HAEMONETICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders